Cardiff Lexington is a diversified holding company that operates much like a cooperative, leveraging proven management in private companies that become subsidiaries under our umbrella. Our current emphasis is on the financial services, healthcare, and real estate sectors. Our platform provides an “Equity Exit or Equity Capitalization” strategy for acquisitions as well as a diversified investment platform for investors that is intended to mitigate risk. Our “Buy and Build” strategy seeks niche companies which complement existing subsidiaries. Our acquisition strategy is driven by structure, transaction value, alignment, resources and return on investment. Our acquisition strategy is not limited by geographic location, and is focused on proven management teams, attractive markets, and historical operating margins. We target acquisitions of mature, high growth, niche companies. Cardiff Lexington’s strategy identifies and empowers select, income-producing, middle market private businesses and commercial real estate properties.
Company profile
Ticker
CDIX, CDIX
Exchange
Website
CEO
Alex H. Cunningham
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CARDIFF INTERNATIONAL INC
SEC CIK
Corporate docs
Subsidiaries
Nova Ortho and Spine, LLC • Edge View Properties, Inc. ...
IRS number
841044583
CDIX stock data
Latest filings (excl ownership)
DEF 14C
Information statement
17 Apr 24
PRE 14C
Preliminary information
5 Apr 24
S-1/A
IPO registration (amended)
5 Apr 24
10-K
2023 FY
Annual report
27 Mar 24
DEF 14C
Information statement
14 Feb 24
S-8
Registration of securities for employees
7 Feb 24
PRE 14C
Preliminary information
31 Jan 24
8-K
Submission of Matters to a Vote of Security Holders
31 Jan 24
8-K
Cardiff Lexington Appoints Matthew Shafer as Chief Financial Officer
4 Jan 24
DEFR14C
Revised information
29 Nov 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 181.34 k | 181.34 k | 181.34 k | 181.34 k | 181.34 k | 181.34 k |
Cash burn (monthly) | 76.62 k | 6.60 k | (no burn) | (no burn) | 99.74 k | 83.62 k |
Cash used (since last report) | 520.91 k | 44.84 k | n/a | n/a | 678.08 k | 568.46 k |
Cash remaining | -339.57 k | 136.50 k | n/a | n/a | -496.74 k | -387.11 k |
Runway (months of cash) | -4.4 | 20.7 | n/a | n/a | -5.0 | -4.6 |
Institutional ownership, Q3 2023
3.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 6.00 k |
Total shares | 355.65 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Adar Alef | 355.65 k | $6.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 24 | Zia Choe | Series I Preferred Stock Common Stock | Other | Acquire J | No | No | 0 | 2,500 | 0.00 | 2,500 |
31 Jan 24 | Matthew T Shafer | Series I Preferred Stock Common Stock | Other | Acquire J | No | No | 0 | 5,000 | 0.00 | 5,000 |
19 Jan 24 | Alex H. Cunningham | Series I Preferred Stock Common Stock | Other | Acquire J | No | No | 0 | 62,500 | 0.00 | 5,743,000 |
19 Jan 24 | Daniel Thompson | Series I Preferred Stock Common Stock | Other | Acquire J | No | No | 0.001 | 62,500 | 62.50 | 5,302,500 |